These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1573 related items for PubMed ID: 32205126

  • 1. Racial disparities in the outcomes of superficial vein treatments for chronic venous insufficiency.
    Pappas PJ, Pappas SF, Nguyen KQ, Lakhanpal S.
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):789-798.e3. PubMed ID: 32205126
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is there an effect of race/ethnicity on early complications of iliac vein stenting?
    Alsheekh A, Hingorani A, Ferm S, Kibrik P, Aurshina A, Marks N, Ascher E.
    Vascular; 2017 Oct; 25(5):549-552. PubMed ID: 28330434
    [Abstract] [Full Text] [Related]

  • 4. Extended Center for Vein Restoration study assessing comparative outcomes for the treatment of chronic venous insufficiency in Medicare- and non-Medicare-eligible patients.
    Pappas PJ, Lakhanpal S, Nguyen KQ, Fernandez E, Sufian S.
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1426-1436.e2. PubMed ID: 33965612
    [Abstract] [Full Text] [Related]

  • 5. Black or African American patients undergo great saphenous vein ablation procedures for advanced venous disease and have the least improvement in their symptoms after these procedures.
    Zil-E-Ali A, DeHaven C, Alamarie B, Paracha AW, Aziz F.
    J Vasc Surg Venous Lymphat Disord; 2023 Sep; 11(5):904-912.e1. PubMed ID: 37343786
    [Abstract] [Full Text] [Related]

  • 6. Race differences in iliofemoral vein stenting for chronic venous insufficiency.
    Cho LD, Bai H, Collins LC, Chen J, Cooke PV, Kang Y, Vasan V, Kim J, Gonzalez C, Dionne E, Kim SY, Ting W.
    Vascular; 2024 Apr; 32(2):385-390. PubMed ID: 36395482
    [Abstract] [Full Text] [Related]

  • 7. The Center for Vein Restoration Study on presenting symptoms, treatment modalities, and outcomes in Medicare-eligible patients with chronic venous disorders.
    Pappas PJ, Lakhanpal S, Nguyen KQ, Vanjara R.
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):13-24. PubMed ID: 29248102
    [Abstract] [Full Text] [Related]

  • 8. Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States.
    Kim EJ, Kressin NR, Paasche-Orlow MK, Lopez L, Rosen JE, Lin M, Hanchate AD.
    BMC Health Serv Res; 2018 May 16; 18(1):370. PubMed ID: 29769083
    [Abstract] [Full Text] [Related]

  • 9. Effect of obesity on chronic venous insufficiency treatment outcomes.
    Deol ZK, Lakhanpal S, Franzon G, Pappas PJ.
    J Vasc Surg Venous Lymphat Disord; 2020 Jul 16; 8(4):617-628.e1. PubMed ID: 32335333
    [Abstract] [Full Text] [Related]

  • 10. The Impact of Race on Advanced Chronic Venous Insufficiency.
    Dua A, Desai SS, Heller JA.
    Ann Vasc Surg; 2016 Jul 16; 34():152-6. PubMed ID: 27179983
    [Abstract] [Full Text] [Related]

  • 11. Advanced Chronic Venous Insufficiency.
    Dua A, Heller JA.
    Vasc Endovascular Surg; 2017 Jan 16; 51(1):12-16. PubMed ID: 28024458
    [Abstract] [Full Text] [Related]

  • 12. Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 States.
    Yan G, Shen JI, Harford R, Yu W, Nee R, Clark MJ, Flaque J, Colon J, Torre F, Rodriguez Y, Georges J, Agodoa L, Norris KC.
    Clin J Am Soc Nephrol; 2020 Jan 07; 15(1):101-108. PubMed ID: 31857376
    [Abstract] [Full Text] [Related]

  • 13. Racial differences in the use of aspirin: an important tool for preventing heart disease and stroke.
    Brown DW, Shepard D, Giles WH, Greenlund KJ, Croft JB.
    Ethn Dis; 2005 Jan 07; 15(4):620-6. PubMed ID: 16259485
    [Abstract] [Full Text] [Related]

  • 14. State-specific prevalence of selected health behaviors, by race and ethnicity--Behavioral Risk Factor Surveillance System, 1997.
    Bolen JC, Rhodes L, Powell-Griner EE, Bland SD, Holtzman D.
    MMWR CDC Surveill Summ; 2000 Mar 24; 49(2):1-60. PubMed ID: 10965781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.
    El Khoudary SR, Samargandy S, Zeb I, Foster T, de Boer IH, Li D, Budoff MJ.
    Nutr Metab Cardiovasc Dis; 2020 Jan 03; 30(1):114-122. PubMed ID: 31761548
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study.
    Arnold JG, Miller AL, Cañive JM, Rosenheck RA, Swartz MS, Mintz J.
    Psychiatr Serv; 2013 Jun 03; 64(6):570-8. PubMed ID: 23494108
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.
    Loja MN, Brunson A, Li CS, Carson JG, White RH, Romano PS, Hedayati N.
    Ann Vasc Surg; 2015 Jul 03; 29(5):950-9. PubMed ID: 25757991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.